UBS Knock-Out TEVA/ DE000UK4MZ37 /
2024-06-07 5:41:57 PM | Chg.+0.020 | Bid5:41:57 PM | Ask5:41:57 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.190EUR | +1.71% | 1.190 Bid Size: 50,000 |
1.200 Ask Size: 50,000 |
Teva Pharmaceutical ... | 4.1346 USD | 2078-12-31 | Call |
Master data
Issuer: | UBS AG, LONDON BRANCH |
---|---|
WKN: | UK4MZ3 |
Currency: | EUR |
Underlying: | Teva Pharmaceutical Industries Ltd |
Type: | Knock-out |
Option type: | Call |
Strike price: | 4.1346 USD |
Maturity: | Endless |
Issue date: | 2022-07-13 |
Last trading day: | 2078-12-31 |
Ratio: | 10:1 |
Exercise type: | Bermuda |
Quanto: | No |
Gearing: | 1.29 |
Knock-out: | 4.1346 |
Knock-out violated on: | - |
Distance to knock-out: | 11.4631 |
Distance to knock-out %: | 75.12% |
Distance to strike price: | 11.4631 |
Distance to strike price %: | 75.12% |
Calculated values
Fair value: | - |
---|---|
Implied volatility: | - |
Historic volatility: | - |
Parity: | - |
Time value: | - |
Break-even: | - |
Moneyness: | - |
Premium: | 0.02 |
Premium p.a.: | 0.00 |
Spread abs.: | 0.01 |
Spread %: | 0.85% |
Delta: | - |
Theta: | - |
Omega: | - |
Rho: | - |
Quote data
Open: | 1.170 |
---|---|
High: | 1.190 |
Low: | - |
Market phase: | - |
All quotes in EUR
Performance
1 Week | -0.83% | ||
---|---|---|---|
1 Month | +27.96% | ||
3 Months | +32.22% | ||
YTD | +98.33% | ||
1 Year | +240.00% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - |
1W High / 1W Low: | 1.200 | 1.170 |
---|---|---|
1M High / 1M Low: | 1.210 | 0.930 |
6M High / 6M Low: | 1.210 | 0.530 |
High (YTD): | 2024-05-14 | 1.210 |
Low (YTD): | 2024-01-02 | 0.630 |
52W High: | 2024-05-14 | 1.210 |
52W Low: | 2023-06-12 | 0.340 |
Avg. price 1W: | 1.186 | |
Avg. volume 1W: | 0.000 | |
Avg. price 1M: | 1.159 | |
Avg. volume 1M: | 0.000 | |
Avg. price 6M: | 0.863 | |
Avg. volume 6M: | 0.000 | |
Avg. price 1Y: | 0.671 | |
Avg. volume 1Y: | 0.000 | |
Volatility 1M: | 64.63% | |
Volatility 6M: | 46.41% | |
Volatility 1Y: | 56.36% | |
Volatility 3Y: | - |